{
  "ticker": "NVO",
  "name": "Novo Nordisk A/S",
  "price": 50.37,
  "market_cap": 223818055680,
  "revenue_ttm": 49642158312.308495,
  "net_income_ttm": 16322771629.36724,
  "ocf_ttm": 19470362843.606667,
  "capex_ttm": 9883351474.465046,
  "sbc_ttm": 0.0,
  "buyback_ttm": 1396604986.8188424,
  "total_debt": 15920258715.607874,
  "cash_and_equivalents": 5125079432.990015,
  "book_value_ttm": 26723459943.752003,
  "shares_outstanding": 3368607341,
  "beta": 1.2,
  "roe": 71.47,
  "analyst_growth_estimate": 5.1,
  "forward_eps": 3.4660072,
  "dividend_yield": 343.0,
  "sector_type": "BioTech",
  "currency_code": "USD",
  "last_updated": "2025-12-16T06:34:31Z"
}